Concepedia

Cara DiCristina

CD

Statistics

Publications

4

Citations

137

H-Index

4

Active since

2015

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Seoul National University Children's Hospital

Erasmus MC - Sophia Children’s Hospital

Cara DiCristina is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, drug safety, and pharmacotherapy.

Top concepts

MedicineDrug SafetyPharmacotherapyPediatricsOncologyAnesthesiaPharmacologyCancer ResearchDrug MonitoringGastroenterology

Publications per year

2015–2019

4

Publications

4

Aprepitant for the prevention of chemotherapy-induced nausea and vomiting in children: a randomised, double-blind, phase 3 trial

Hyoung Jin Kang, Susan Loftus, Arlene Taylor et al. · The Lancet Oncology · 2015 · 95 citations

Drug Safety, Chemotherapy-induced Nausea, Pediatric Epidemiology +5

Pharmacokinetics and pharmacodynamics of aprepitant for the prevention of postoperative nausea and vomiting in pediatric subjects

F. Tansu Salman, Cara DiCristina, Anne Chain et al. · Journal of Pediatric Surgery · 2018 · 18 citations

Drug Safety, Gastroenterology, Pediatrics +6

Pharmacokinetics/pharmacodynamics, safety, and tolerability of fosaprepitant for the prevention of chemotherapy‐induced nausea and vomiting in pediatric cancer patients

Jaume Mora, Miguel Valero, Cara DiCristina et al. · Pediatric Blood & Cancer · 2019 · 14 citations

Drug Safety, Therapeutic Drug Monitoring, Emetogenic Chemotherapy +13

Aprepitant for the prevention of chemotherapy‐induced nausea and vomiting in paediatric subjects: An analysis by age group

Hyoung Jin Kang, Susan Loftus, Cara DiCristina et al. · Pediatric Blood & Cancer · 2018 · 10 citations

1–4 of 4